ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Prescribing Medical Psychologist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,114Medicare Part D Prescriptions Filled, Including Refills
$1.35M Total Retail Price of All Prescriptions
580 Patients Receiving at Least One Drug in Part D
34%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
RISPERIDONE 861 136
TRAZODONE HCL 662 220
ZOLPIDEM TARTRATE 594 200
SERTRALINE HCL 488 188
ZIPRASIDONE HCL 466 26 10
BENZTROPINE MESYLATE 405 0 R
OLANZAPINE 392 14
BUPROPION XL 364 98
CITALOPRAM HBR 353 153
DIVALPROEX SODIUM 332 41
DONEPEZIL HCL 315 242
SEROQUEL XR 296 28
PAROXETINE HCL 290 123
DIVALPROEX SODIUM ER 288 40
FLUOXETINE HCL 258 65
BUPROPION HCL SR 246 130
ABILIFY 242 37
LAMOTRIGINE 239 39
ESCITALOPRAM OXALATE 230 72
CLONAZEPAM 218 82
HALOPERIDOL 217 20
TRIFLUOPERAZINE HCL 216 83
BUSPIRONE HCL 201 53
MIRTAZAPINE 198 51
ALPRAZOLAM 190 106
OXCARBAZEPINE 170 11
VENLAFAXINE HCL ER 167 63
NAMENDA 155 133
TEMAZEPAM 154 74
CYMBALTA 146 57
GEODON 139 0
LITHIUM CARBONATE 137 32
CLOZAPINE 115 0
QUETIAPINE FUMARATE 91 0
LEXAPRO 85 30
TOPIRAMATE 82 22
CARBAMAZEPINE 79 0
ZYPREXA 74 0
AMITRIPTYLINE HCL 63 29 R
INVEGA 63 0
AMPHETAMINE SALT COMBO 61 0 S2
HYDROXYZINE PAMOATE 60 0 R
THIOTHIXENE 57 0
PRISTIQ ER 55 16
LORAZEPAM 52 36
FLUPHENAZINE HCL 50 0
CHLORPROMAZINE HCL 50 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.